WHO warning: No evidence that antibody tests can show coronavirus immunity

WHO warning: No evidence that antibody tests can show coronavirus immunity

The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release

Read more
FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment. The application, submitted by Accord Healthcare, was approved on April 7. The approved indications are uncomplicated malaria due to Plasmodium falciparum, P. malariae, P. ovale, and P. vivax; chronic discoid lupus erythematosus and systemic lupus erythematosus in adults; and acute and chronic rheumatoid arthritis in adults.

Read more
Hydroxychloroquine and its effectiveness against COVID-19 treatment

Hydroxychloroquine and its effectiveness against COVID-19 treatment

Some politicians and doctors are sparring over whether to use Hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now. The drug Hydroxychloroquine can help tame an overactive immune system. It’s been used since the 1940s to prevent and treat malaria, and to treat rheumatoid arthritis and lupus. It’s sold in generic form and under the brand name Plaquenil in the United States. Doctors also can prescribe it off label for other purposes, as many are doing now for COVID-19.

Read more
Taj Pharmaceuticals FDA Approvals of Oseltamivir Continues the Company Rise in the Generic Market

Taj Pharmaceuticals FDA Approvals of Oseltamivir Continues the Company Rise in the Generic Market

Oseltamivir Phosphate Capsules 75 mg – Manufacturer in India, Taj Pharma Oseltamivir Phosphate Capsules Supplier, Oseltamivir Phosphate Capsules Exporter Taj Pharma
Oseltamivir phosphate capsules, Oseltamivir Phosphate capsules manufacturers, Oseltamivir suppliers, Oseltamivir exporters in India, Get contact details & address of company manufacturing, Oseltamivir phosphate capsules
oseltamivir capsules 75 mg price, oseltamivir dose, oseltamivir interactions, oseltamivir warnings, tamiflu generic hallucinations, tamiflu generic side effects kids, how long do tamiflu side effects last
oseltamivir generic name, related to oseltamivir phosphate, oseltamivir phosphate cost, oseltamivir phosphate 75mg, oseltamivir interactions, oseltamivir warnings, oseltamivir mechanism of action, oseltamivir phosphate reviews, Oseltamivir generic, tamiflu generic

Read more